Join the Iowa Biotechnology Association

The Iowa Biotechnology Association (IBA) was formed in 1994 to advance opportunities in Iowa for the improvement of the human environmental and economic well-being through the development and application of value-added technologies in the life sciences.

Working cooperatively, the members hope to enhance the ability to commercialize new technologies in a timely manner and reduce the lead time for deployment. Activities of the association are designed to give companies doing business in Iowa an edge in delivering timely new products to consumers through the sharing of ideas regarding the transfer and development of technologies.

Learn About Iowa's BioHistory

Through Iowa BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industries in the state of Iowa.

Local News...

Free News Release Posting & Archiving Service


• Primovist(R) approved in the U.S. for the detection and characterization of liver lesions  The U.S. Food and Drug Administration has approved Bayer Schering Pharma’s magnetic resonance imaging contrast agent Primovist(R) (gadoxetate disodium) for the detection and characterization of liver lesions in adults with known or suspected focal liver disease.
  Bayer  July 08, 2008  
  
  
• FDA grants Invitrogen premarket approval of breast cancer test  Invitrogen announced it has received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its SPOT-Light(R) HER2 CISH Kit, indicated as an aid in the assessment of breast cancer patients for whom trastuzumab (Herceptin(R)) treatment is being considered.
  Invitrogen Corporation  July 08, 2008  
  
  
• Herculean device for molecular mysteries  A privately financed team of scientists and engineers is nearing completion of a special-purpose supercomputer intended to offer more than a thousandfold increase in performance for complex molecular simulations.
  The New York Times  July 08, 2008  John Markoff
  
  
• Wyeth applauds inclusion of the PCV7 vaccine in countries' immunization schedules  Wyeth applauds the countries of Cyprus, Hungary, the Kingdom of Bahrain, Republic of Ireland, Slovak Republic and Sweden for announcing their decisions to routinely immunize infants and young children against pneumococcal disease by adding PREVENAR(TM) PCV7 to their national immunization programs.
  Wyeth  July 08, 2008  
  
  
• Lilly to acquire SGX Pharmaceuticals  Eli Lilly and Company and SGX Pharmaceuticals announced that the companies have signed a definitive merger agreement providing for the acquisition of SGX in an all-cash transaction.
  Eli Lilly and Company  July 08, 2008  
  
  

More... | Submit News Release | National News

New Job Postings...

Free Job Posting Trial Offer

• Quality Engineer AlloSource (CO)
• Machinist/Fabricator AlloSource (CO)
• Maintenance Engineer AlloSource (CO)
• Senior Application Specialist (biochemistry analyzer product line) Mindray Medical USA Corp. (WA)
• Research Technician II Benaroya Research Institute (WA)

More... | Job Advertising... | About Job Postings...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

• Charter Construction Lab Building -- Seattle, WA
• Icogenex Biotech Incubator -- Seattle, WA
• Syntrix Biosystems Start-up Lab Space -- Auburn, WA
• University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
• University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

Free Event Posting Service

• 07/08/2008: Reimbursement SIG Presents: Avoiding Government Scrutiny in Reimbursement: The Kyphon Case and Beyond
• 07/14/2008: AUTM Central Region Meeting
• 07/14/2008: Trial Design Innovation Conference
• 07/14/2008: AUTM Central Region Meeting
• 07/17/2008: Next Generation Vaccines

More... | Submit Event | Event Advertising...